Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
53,480,524
-
Share change
-
-1,756,290
-
Total reported value
-
$839,068,026
-
Put/Call ratio
-
30%
-
Price per share
-
$15.69
-
Number of holders
-
187
-
Value change
-
-$31,785,679
-
Number of buys
-
90
-
Number of sells
-
81
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2021
As of 31 Dec 2021 Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) had 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 53,480,524 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, Palo Alto Investors LP, LSV ASSET MANAGEMENT, DIMENSIONAL FUND ADVISORS LP, Epoch Investment Partners, Inc., and GOLDMAN SACHS GROUP INC.
This table shows 187 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.